Trials / Conditions / Klebsiella Pneumonia

Klebsiella Pneumonia

5 registered clinical trials studyying Klebsiella Pneumonia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg Tablets with the Partic NCT06815549	Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation	Phase 3
Unknown	Clinical Outcomes in Patients With Infection by Resistant Microorganism NCT05880069	Hospital Universitario Virgen Macarena	—
Completed	Turkish Prospective Cohort Study on Carbapenem Resistant Klebsiella Pneumonia Bacteremia NCT03597841	Koç University	—
Completed	Double Carbapenem as Rescue Strategy for the Treatment of Carbapenemase-Producing Klebsiella Pneumoniae Infect NCT03094494	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Completed	Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms NCT01324726	American University of Beirut Medical Center	—